Last reviewed · How we verify

NCT03803527

Metabolomic Profiling of Eosinophilic Esophagitis

Withdrawn NA Last updated 17 October 2019
What this trial tests

NA trial testing Esophageal String Test in Eosinophilic Esophagitis. Withdrawn.

Timeline
1 December 2019
Primary endpoint
1 February 2021
1 August 2021

Quick facts

Lead sponsorUniversity of Colorado, Denver
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Start date1 December 2019
Primary completion1 February 2021
Estimated completion1 August 2021

Drugs / interventions tested

Conditions studied

Sponsor

University of Colorado, Denver

Who can join

Adults 11 to 55, any sex, with Eosinophilic Esophagitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A prospective longitudinal, observational study of adolescent and adults that will identify novel metabolites associated with dysphagia in Eosinophilic Esophagitis (EoE).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Esophageal String Test

Trials testing the same drug.

Other recruiting trials for Eosinophilic Esophagitis

Currently open trials in the same condition.

Other University of Colorado, Denver trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03803527.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing